These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 24618499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial.
    Moreno I, Belinchon A.
    Ear Hear; 2022; 43(2):676-684. PubMed ID: 34483247
    [Abstract] [Full Text] [Related]

  • 5. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
    Daldal A, Odabasi O, Serbetcioglu B.
    Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intratympanic Dexamethasone Role in Hearing Protection in Cancer Patients.
    Gupta D, Singh G, Garg P, Dey R, Singh B.
    Cureus; 2023 Aug; 15(8):e44299. PubMed ID: 37779780
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M.
    J Otolaryngol Head Neck Surg; 2019 Jan 16; 48(1):4. PubMed ID: 30651130
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG, Elkabarity RH, Thabet MT, Soliman NB, Kalleny NK.
    Auris Nasus Larynx; 2013 Feb 16; 40(1):51-60. PubMed ID: 22884636
    [Abstract] [Full Text] [Related]

  • 12. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
    Sarafraz Z, Ahmadi A, Daneshi A.
    Int Tinnitus J; 2018 Jun 01; 22(1):40-45. PubMed ID: 29993216
    [Abstract] [Full Text] [Related]

  • 13. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Jun 01; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hearing assessment of children treated with Cisplatin].
    Mniszek J, Bielecki I, Sobol G.
    Pol Merkur Lekarski; 2009 Aug 01; 27(158):105-8. PubMed ID: 19856874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW, Morest DK, Parham K.
    Otol Neurotol; 2008 Oct 01; 29(7):1005-11. PubMed ID: 18716567
    [Abstract] [Full Text] [Related]

  • 20. The protective effect of intratympanic dexamethasone on streptomycin ototoxicity in rats.
    Gül A, Şengül E, Yılmaz B, Özkurt FE, Akdağ M, Keleş A, Topçu İ.
    Ear Nose Throat J; 2017 Jun 01; 96(6):E12-E17. PubMed ID: 28636736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.